TKIs improve survival in EGFR mutation positive lung cancer

European patients with mutation-positive epidermal growth factor receptor non small cell lung cancer should undergo routine baseline tissue-based mutation assessment and treatment with EGFR tyrosine-kinase inhibitors, suggest study findings. (Source: MedWire News - Breast Cancer)

Source: http://www.medworm.com/index.php?rid=5866189&cid=u_0_6_f&fid=36308&url=http%3A%2F%2Fwww.medwire-news.md%2F380%2F98550%2FBreast_Cancer%2FTKIs_improve_survival_in_EGFR_mutation_positive_lung_cancer_.html

phlebotomy training in nj phlebotomy training nj phlebotomy courses in ny